Preparing for the introduction of HPV vaccines: policy and programme guidance for countries

2006 - 25 pages

This guidance note is based on a UNFPA/WHO Technical Consultation on HPV Vaccines and Sexual and Reproductive Health Programmes, held in March 2006 in Montreux, Switzerland. It is intended to alert a broad array of stakeholders – in sexual and reproductive health, immunization, child and adolescent health, and cancer control programmes – to some of the key issues surrounding the upcoming introduction of human papillomavirus (HPV) vaccines against cervical cancer.

Content

Cervical cancer and HPV infection

Vaccines against HPV

Target populations for HPV immunization

Innovative features of HPV vaccines

A unique opportunity

An expensive product

Introduction challenges

Not business as usual

Advocacy, information and communication

Action points

Service delivery

Reaching target populations

Partnerships between programmes

Monitoring and evaluation

Action points

Stewardship and financing

Action points

Epilogue

Additional resources